The ability of sense peptides (coded for by sense DNA) and corresponding antisense peptides (coded for by corresponding antisense DNA) to interact specifically was used to design antisense peptide inhibitors of interleukin‐1 isoforms IL‐1β and IL‐1α. These inhibitors appear to act as “mini receptors”, binding to both isoforms and thereby sterically blocking the normal interaction between interleukin‐1 and its receptors.
No takes yet. Share an insight, caveat, or question.
Davids et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: